Grove (GROV) Q2 2026 Earnings Call Transcript

Grove Collaborative reported Q2 net revenue of $36.6M, down 16.9% YoY but up 1% sequentially, while adjusted EBITDA improved to $0.5M (1.3% margin) for the third straight quarter of positive results. The company cut operating expenses 27% YoY (to $20.4M) and generated positive operating cash flow of $1.3M, ending the quarter with $11.4M cash, cash equivalents, and restricted cash. DTC total orders fell 23.6% YoY to 489k, but DTC net revenue per order rose 6.1% to $69.19. Full-year 2026 guidance was reaffirmed at $142.5M–$152.5M net revenue and adjusted EBITDA breakeven to positive low single-digit millions.

Analysis

The near-term setup is more about balance-sheet survival and sentiment than a true growth inflection. GROV has shown it can strip costs fast enough to print cash, which lowers dilution risk and can support a higher EV/revenue multiple, but the underlying demand engine is still shrinking; if ad spend ramps before retention actually stabilizes, the company can easily give back the EBITDA gains. The market is likely to focus on sequential improvement, but the more important question over the next 1-3 quarters is whether customer cohorts are healing or whether the company is simply harvesting the remaining base more efficiently.

The biggest second-order effect is channel mix. Pushing deeper into Amazon and drop-ship can improve assortment breadth and working-capital efficiency, but it also shifts GROV toward a lower-control, lower-loyalty model where pricing power and repeat economics are weaker. That creates a subtle winner in suppliers/brand partners that can piggyback on GROV's trust halo without taking inventory risk, while the loser is the company's own DTC moat if marketplace traffic becomes a crutch rather than an acquisition funnel.

The CFO transition is a real risk factor because this story is now a cash-allocation and payback-period story, not a pure branding story. Over 1-3 months, the stock can trade better if management proves it can reaccelerate orders without burning cash; over 6-18 months, the thesis breaks if the sequential revenue gains stall once advertising is normalized. Watch for any guidance that implies ad spend rises faster than active customers or that drop-ship meaningfully compresses gross margin; those would falsify the current stabilization narrative.

Contrarian view: the consensus may be underestimating how much operating leverage exists if gross revenue merely stabilizes, but it may also be overestimating the durability of the current margin structure. This is a classic small-cap turnaround where the first P&L inflection is easier than the second, because the next leg requires actual customer re-acceleration, not just expense cuts. If the company cannot show net customer adds by the next earnings cycle, the market will likely reprice the equity back toward a liquidation-style multiple rather than a growth multiple.

Key Decisions for Investors

• Tactically long GROV for 2-6 weeks only if the post-earnings reaction holds above the prior resistance zone; the trade is a sentiment squeeze on liquidity improvement, but trim aggressively if active customers or orders fail to inflect next quarter.
• Do not chase the name on the EBITDA print alone; wait for the next 1-2 monthly operating updates or the next quarter's customer metrics to confirm that ad spend is converting before adding risk.
• Pair idea: long AMZN / short GROV on any rally if the market starts rewarding the Amazon-channel narrative. The short leg is a hedge against GROV's dependence on marketplace distribution that can erode DTC economics; the long leg captures the secular winner of traffic consolidation.
• If you want to express the turnaround cautiously, use a small call spread in GROV with a 1-3 month horizon and a hard stop on any guidance reset or margin compression from higher advertising spend.
• Watch item rather than recommendation: if management's next update shows ad spend rising faster than revenue and gross margin slipping again, the thesis is likely broken and the stock should be treated as a value trap rather than a recovery story.